Home Tags Posts tagged with "HHS"

HHS

HHS Distributing an Additional $413 Million in Provider Relief Fund Payments

Mar 23, 2022

0 1854

Message from the Provider Relief Bureau of the Health Resources and Services Administration (HRSA):

HRSA is making more than $413 million in Provider Relief Fund (PRF) Phase 4 General Distribution payments to more than 3,600 providers across the country this week.

Providers received an email notification Monday, March 21 if their application was among those processed in this latest batch. HRSA is working to review all remaining applications as quickly as possible.

With this announcement, a total of nearly $12 billion in PRF Phase 4 payments has now been distributed to more than 82,000 providers in all 50 states, Washington D.C., and five territories. This is in addition to HRSA’s distribution of American Rescue Plan (ARP) Rural payments, totaling nearly $7.5 billion in funding to more than 44,000 providers since November 2021.

Learn More

HHS updated the state-by-state table detailing all Phase 4 payments made to date.
As individual providers agree to the terms and conditions of Phase 4 payments, it will be reflected on the public dataset.

OIG Clears the Way for Use of Financial Incentives in Treating SUD Within the Medicaid Population

Mar 9, 2022

0 2326

The Office of Inspector General (OIG) within the U.S. Department of Health and Human Services (HHS) has issued a favorable advisory opinion regarding contingency management (CM), an evidence-based approach for treating substance use disorders (SUD) that uses financial incentives to reward healthy behavior, such as abstinence and treatment retention, according to the National Council for Mental Wellbeing.

CM has been shown to be an effective approach for those with SUD in more than 100 randomized controlled trials over 50 years. Evidence shows it can double abstinence rates across opioids, stimulants, alcohol, tobacco, and nicotine, compared to usual care alone. It is the most effective and most evidence-based treatment for stimulant use disorders. In 2021, the Biden Administration declared advancing CM among its drug policy priorities.

The advisory opinion clears the way for CM for routine use in publicly funded substance use treatment programs and healthcare facilities under federal reimbursement, including Medicaid.

Read the full press release.